First Hawaiian Bank Regeneron Pharmaceuticals, Inc. Transaction History

First Hawaiian Bank

$3.05 Billion
Q3 2024

A detailed history of First Hawaiian Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, First Hawaiian Bank holds 2,521 shares of REGN stock, worth $1.8 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,521

Previous 2,624 3.93%

Holding current value

$1.8 Million

Previous $2.76 Million 3.88%

% of portfolio

0.09%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$1024.09 - $1201.76 $105,481 - $123,781	-103 Reduced 3.93%	2,521 $2.65 Million
Q2 2024 Jul 02, 2024	SELL	$883.2 - $1071.19 $31,795 - $38,562	-36 Reduced 1.35%	2,624 $2.76 Million
Q1 2024 Apr 05, 2024	SELL	$902.69 - $993.35 $450,442 - $495,681	-499 Reduced 15.8%	2,660 $2.56 Million
Q4 2023 Jan 08, 2024	SELL	$775.18 - $881.7 $549,602 - $625,125	-709 Reduced 18.33%	3,159 $2.77 Million
Q3 2023 Oct 10, 2023	BUY	$692.45 - $844.37 $4,154 - $5,066	6 Added 0.16%	3,868 $3.18 Million
Q2 2023 Jul 06, 2023	BUY	$700.03 - $830.35 $161,706 - $191,810	231 Added 6.36%	3,862 $2.78 Million
Q1 2023 Apr 18, 2023	SELL	$680.49 - $826.97 $689,336 - $837,720	-1,013 Reduced 21.81%	3,631 $2.98 Million
Q4 2022 Jan 12, 2023	BUY	$705.89 - $766.39 $312,709 - $339,510	443 Added 10.55%	4,644 $3.35 Million
Q3 2022 Oct 05, 2022	SELL	$573.97 - $724.32 $65,432 - $82,572	-114 Reduced 2.64%	4,201 $2.89 Million
Q2 2022 Jul 22, 2022	SELL	$548.35 - $738.84 $190,825 - $257,116	-348 Reduced 7.46%	4,315 $2.55 Million
Q1 2022 Apr 06, 2022	BUY	$595.12 - $698.43 $1.42 Million - $1.67 Million	2,388 Added 104.97%	4,663 $3.26 Million
Q4 2021 Jan 12, 2022	SELL	$543.48 - $670.97 $55,978 - $69,109	-103 Reduced 4.33%	2,275 $1.44 Million
Q3 2021 Oct 12, 2021	SELL	$574.03 - $680.96 $2,870 - $3,404	-5 Reduced 0.21%	2,378 $1.44 Million
Q2 2021 Jul 08, 2021	SELL	$472.8 - $558.54 $497,858 - $588,142	-1,053 Reduced 30.65%	2,383 $1.33 Million
Q1 2021 Apr 09, 2021	BUY	$446.73 - $548.2 $79,517 - $97,579	178 Added 5.46%	3,436 $1.63 Million
Q4 2020 Jan 12, 2021	BUY	$478.3 - $607.98 $560,567 - $712,552	1,172 Added 56.18%	3,258 $1.57 Million
Q3 2020 Oct 06, 2020	SELL	$544.75 - $658.21 $200,468 - $242,221	-368 Reduced 15.0%	2,086 $1.17 Million
Q2 2020 Aug 05, 2020	SELL	$493.32 - $643.92 $197,328 - $257,567	-400 Reduced 14.02%	2,454 $1.53 Million
Q1 2020 Apr 21, 2020	SELL	$336.18 - $494.43 $314,328 - $462,292	-935 Reduced 24.68%	2,854 $1.39 Million
Q4 2019 Jan 13, 2020	BUY	$274.13 - $376.51 $207,790 - $285,394	758 Added 25.01%	3,789 $1.42 Million
Q2 2019 Jul 15, 2019	SELL	$299.6 - $414.82 $254,660 - $352,597	-850 Reduced 21.9%	3,031 $949,000
Q1 2019 Apr 02, 2019	SELL	$372.08 - $439.57 $29,766 - $35,165	-80 Reduced 2.02%	3,881 $1.59 Million
Q4 2018 Jan 11, 2019	BUY	$335.82 - $403.04 $116,193 - $139,451	346 Added 9.57%	3,961 $1.48 Million
Q3 2018 Oct 16, 2018	BUY	$351.14 - $408.51 $1.27 Million - $1.48 Million	3,615 New	3,615 $1.46 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.

Account

First Hawaiian Bank Regeneron Pharmaceuticals, Inc. Transaction History